Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Driven by 4 papers. Top paper: “Immune signatures to affect overall survival (OS) and response to bevacizumab (Bev) or cetuximab (Cet) in patients (pts) with metastatic colorectal cancer (mCRC) of CALGB/SWOG 80405 (Alliance).”.
Akram Yazdani, Xueping Qu, Fang‐Shu Ou, Scott Van Buren, Omar Kabbarah +5 more
Xueping Qu, Chu-Fang Lin, Ling‐Yuh Huw, Avinashnarayan Venkatanarayan, Ethan Sokol +14 more
Akram Yazdani, Naim Rashid, Xueping Qu, Fang‐Shu Ou, Scott Van Buren +7 more
Akram Yazdani, Naim U. Rashid, Xueping Qu, Fang‐Shu Ou, Scott Van Buren +7 more